These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6759928)

  • 1. [Immunological classification of acute lymphoblastic leukemias (ALL) in childhood. Origin and clinical significance of phenotypic variability].
    Thöne I; Kabisch H; Müller J; Winkler K; Landbeck G
    Monatsschr Kinderheilkd; 1982 Dec; 130(12):883-90. PubMed ID: 6759928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
    Feller AC
    Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
    Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
    Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukemias].
    Ugazio AG
    Pediatr Med Chir; 1985; 7(2):177-9. PubMed ID: 2937023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute lymphoblastic leukemia in children. The use of antisera specific for lymphocyte populations in a classification trial].
    Andary M; Clot J; Brochier J; Levallois C; Dossa D; Marguerite G; Jean R
    Arch Fr Pediatr; 1979; 36(8):751-9. PubMed ID: 317241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic cell markers in acute lymphoblastic leukemia in children].
    Grigor'iants LIa
    Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological definition of leukemic cell surface phenotypes.
    Melvin SL
    Cancer Res; 1981 Nov; 41(11 Pt 2):4790-3. PubMed ID: 6975161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploitation of monoclonal antibodies: a "who's who" of haemopoietic malignancy.
    Greaves MF; Delia D; Robinson J; Sutherland R; Newman R
    Blood Cells; 1981; 7(2):257-80. PubMed ID: 7028183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia: classification and characterization with antisera to human T-cell and Ia antigens.
    Anderson JK; Moore JO; Falletta JM; Terry WF; Metzgar RS
    J Natl Cancer Inst; 1979 Feb; 62(2):293-8. PubMed ID: 310908
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological phenotypes of human leukemias of the B-cell lineage.
    Seligmann M; Vogler LB; Preud'Homme JL; Guglielmi P; Brouet JC
    Blood Cells; 1981; 7(2):237-46. PubMed ID: 6975140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The heterogeneity of human lymphoid leukemias unmasked by immunological studies of membrane markers (author's transl)].
    Seligmann M; Brouet JC; Preud'homme JL
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):339-50. PubMed ID: 303356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias].
    González M; Tamagnini G; San Miguel JF; Lopes DT; Mateos G; Caballero MD; Ribeiro L; López Borrasca A
    An Esp Pediatr; 1984 Sep; 21(3):222-8. PubMed ID: 6594963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
    Pituch-Noworolska A; Miezyński W
    Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.